© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Kitasamycin stands out as a macrolide antibiotic, valued mainly in both veterinary and agricultural health practices. It gets its name from the actinomycete species Streptomyces kitasatoensis, which produces this compound naturally during fermentation. Many know it for its ability to halt bacterial protein synthesis, knocking back pathogens that trouble livestock, poultry, and even certain crops. What makes Kitasamycin distinct among other antibiotics comes from its targeted action against Gram-positive bacteria and a handful of Gram-negative strains, which positions it as a go-to solution when resistance becomes an issue with older, mainstream antimicrobials.
You find Kitasamycin in several physical forms: fine powder remains the most common, but flakes, crystals, and pearls also appear in trade. In most raw material applications, the substance looks off-white or yellowish, rarely clear, and gives off a faint organic odor typical for fermentation-derived antibiotics. Densities can shift a bit between forms. The powder has a density near 0.6–0.7 g/cm³, with crystal forms registering higher. Kitasamycin rarely arrives in liquid or ready-to-use solution for shipping, but dissolves in organic solvents or diluted alcohol to form stable solutions for testing or feed additive preparations. Each batch often ships in airtight drums to keep moisture and light from breaking down active contents before use.
Chemistry gives Kitasamycin the molecular formula C35H59NO13. Researchers map its structure as a large macrocyclic lactone ring characteristic of macrolides—inside that ring sits one deoxy sugar and one amino sugar, which help the molecule bind to bacterial ribosomes. Each part of Kitasamycin’s molecule takes up a unique spot on NMR and IR spectra, so quality labs fingerprint batches before release. With a molar mass of 701.85 g/mol, each molecule binds water poorly—so it dissolves best in ethanol, methanol, or acetone. This fact helps keep the active ingredient stable even in humid environments if it stays sealed properly.
Trading across borders uses the Harmonized System Code (HS Code) of 2941.90 for Kitasamycin as a macrolide antibiotic. This code streamlines customs checks in nearly every major producing and importing country, covering bulk shipments for animal pharmaceutical use. Raw material suppliers and formulation plants must reference this code and meet import documentation requirements, which typically focus on antimicrobial residues, stability, and traceability back to the fermentation source. Knowing the correct HS Code for Kitasamycin avoids customs barriers and speeds up processing at major chemical ports.
At room temperature, Kitasamycin stays stable as a solid. Melting points start at 153°C, but heat or direct sunlight will prompt slow degradation over months. The antibiotic does not give off significant fumes or vapor; it does not boil as a solid, but decomposition starts above 180°C with acrid smoke. Once dissolved, solutions show faintly acidic pH, running near 5.5–7. Powdered samples resist clumping with gentle handling, yet standard humidity triggers slow caking unless the drum closes tightly after every use. Its solubility in water measures low, usually under 0.01 mg/mL. Most working suspensions in feed or water require a solvent or surfactant to keep the antibiotic active and spread evenly among animal feed or treatment baths.
Kitasamycin rates as a hazardous chemical chiefly due to inhalation or skin exposure risks. Technicians report mild irritation to eyes and mucous membranes from long handling. Because it targets bacteria, improper contact could set off allergies or, in rare cases, disrupt the normal human gut flora. Standard personal protective equipment (PPE) during handling makes all the difference: gloves, dust mask or respirator, goggles, and sleeves keep skin and airways safe. Production areas use local exhaust systems and keep emergency eyewash stations close at hand. While acute toxicity for mammals sits low compared to many industrial chemicals, Kitasamycin cannot go in household waste streams. Regulations in Europe, the US, and China set limits on antibiotic residues found in consumer food, driving manufacturers to maintain strict record-keeping from fermentation tank to finished pellet.
Fermentation drives Kitasamycin production, with Streptomyces kitasatoensis grown in liquid tanks fed with soybean meal, glucose, calcium carbonate, and trace minerals. Producers need consistent quality in every raw input, since the actinomycete’s yield and purity drop with variable feedstock. Downstream, filters and resins separate the crude product, which goes through several crystallization and drying cycles to extract pure, saleable antibiotic. Unlike synthetic small molecules, nature provides most of the molecule’s intricate ring system, so chemical tweaking stays minimal. Chemical waste includes spent mycelia, mineral salts, and alcohols from purification—each flow needs special treatment on-site to stop both chemical pollution and antibiotic release into rivers or municipal systems.
Most Kitasamycin produced globally gets blended into medicated feed premixes, injectable solutions, or oral suspensions for pigs, chickens, and sometimes aquaculture. It prevents common bacterial infections, improves growth rates, and, in some regions, still finds use while newer antibiotics remain under regulatory review. Human use faded in most countries due to newer, safer macrolides but some Asian nations include Kitasamycin among last-resort options for Mycoplasma or resistant pathogens. Feed manufacturers track inclusion levels to avoid exceeding maximum residue limits, as testing picks up antibiotic traces in eggs, meat, and milk destined for supermarkets. Each supply chain partner—from fermentation tank operator to end-buyer—shares legal and ethical responsibility for proper stewardship, resisting pressure to overuse antibiotics as economic insurance.
Much discussion around Kitasamycin centers on antibiotic resistance and ecological harm. Unchecked release into soil or water, even at trace levels, can spark resistant pockets of bacteria in the environment. Farms using medicated feed must collect manure and bedding, composting or treating waste to lower the antibiotic load before field spreading. Waterways downstream from feedlots or manufacturing plants carry a real risk of resistance transfer, which pushes the global medical community to call for tighter permit inspection and public disclosure. Every producer benefits from closing material loops, investing in waste pretreatment systems, and joining consortiums that share best practices—tactics shown in global livestock regions with declining resistance statistics.
Responsibility means more than regulatory compliance. Buyers and producers checking each delivery against batch certificates and independent lab analysis reduce the risk of contamination or mislabeling. Supply chain audits, both internal and third-party, slash the odds of counterfeit antibiotics or dangerous impurities sneaking into public networks. Worker health programs, regular PPE training, and chemical hygiene plans protect not just staff but local communities exposed via air or water. Ongoing research into greener production uses less harsh solvents, greener purification cycles, and recovery of spent biomass for soil health—all contributions to a more sustainable Kitasamycin industry.
